chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The area of my arm where the shot was administered became hot,  swollen and red. This happened within 8 hours of shot. When I woke up the next morning, the site was raised and swollen more than the night before. It had the appearance of cellulitis. It was still hot to the touch. I marked the edges of the rash and it progressively got bigger over the course of 48 hours. I still have a mark on my arm where the rash was. I also had severe jaw and neck pain. I felt like my wisdom teeth were pulled with no lidocaine.  I has boughts of nausea and was very tired. I tried to put ice on the area of my arm that was swollen, but it did not help.
muscle pain in his upper back between the shoulder blades/In my upper middle back, between my shoulder blades is very painful and it is like a muscle pain; It is limiting the movement of his left arm somewhat; he has sharp stabbing pain.; This is a spontaneous report from a contactable consumer (patient himself). A 63-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 23Jul2021 10:00 (age at vaccination: 63 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 23Jul2021, the patient experienced severe muscle pain in his upper back between the shoulder blades/in my upper middle back, between my shoulder blades is very painful and it is like a muscle pain, it was limiting the movement of his left arm somewhat; on an unknown date in July2021, he had sharp stabbing pain. Pain was a little more than mild. It was limiting the movement of his left arm somewhat. He states it would be an issue with putting on a t shirt for the left arm. Sometimes he has sharp stabbing pain. He denies having fever. The patient was taking Tylenol for myalgia. It was quite severe. He had taken Tylenol twice already today. There was no pain at all at the injection site. The outcome of the events was not recovered. There was no product quality complaint (PQC) present.  Information on the lot/batch number has been requested.
Headache, nausea, vomiting, chills, confusion. Lasted 6 hours.   Headache lasted two weeks.   Swelling around spine, neck, shoulders, is still on-going but getting better. I had loss of bowl control for a day. Headaches severe. Trouble sleeping still. Arm still sore.
Headache Body ache, sore throat, right arm numbness.  Narrative:  Other Relevant History:
Information has been received from a healthcare worker referring to unspecified number of patients of unknown age and gender. There was no information about the patient's medical history and concurrent condition. On unknown dates these patients were vaccinated with improperly stored VARIVAX (Merck) (lot # K007785, expiration date: 28-MAY-2016, strength, dose and route unknown) (incorrect product storage). There was no information about concomitant therapy. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient received 3rd GARDASIL 10:10 AM 4/9/12. At noon felt nausea. Returned to Health Services 2 PM with foreign body sensation in throat. Given Epi/BENADRYL and sent to ER. Given Prednisone at ER and discharged. Service 4 AM 4/10/12 with foreign body sensation - not as intense. Treated with Prednisone, ZYRTEC in our office 4/10/12 11:30. Better next 24 hours.
Patient reports pain, swelling, warmth at injection site beginning 2-3 days after Tdap injection was given. Reported feverishness, temperature was not taken by patient. Swelling and redness at location of bicep and elbow on day patient seen in clinic, no redness at injection site on 1/3/17.
8/11 (L) arm sore, swollen and tender to touch. 8/14 spoke w/mother and she states arm better in 24 hours.
After about 16 minutes, the patient reported that her arms were feeling hot. When she took off her jacket, her arms were red.
This spontaneous report as received from a pharmacist refers to a 72 years old female patient with prophylaxis. The patient was vaccinated with dose 1, 0.5 ml PNEUMOVAX23 (intramuscular, Lot# H013847, exp 14-MAR-2015 on 16-OCT-2012. Other suspect therapies included FLUZONE with dosage information as (UNK) on 16-OCT-2012. No concomitant medications were reported. On 16-OCT-2012 the patient reported she received an unspecified pneumococcal vaccination at an unspecified time last year. Patient stated that she was experiencing fever and the arm where vaccine administered was "distorted" but no tenderness or rash. Reporter stated FLUZONE HD was administered concomitantly with PNEUMOVAX 23 on 16-OCT-2012. Additional information is requested.
shingles rash; vesicular rash; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2020, the patient received the 1st dose of Shingrix. In September 2020, less than 2 weeks after receiving Shingrix, the patient experienced shingles and vesicular rash. On an unknown date, the outcome of the shingles and vesicular rash were unknown.   It was unknown if the reporter considered the shingles and vesicular rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, but it could be 51 or 52 year.  The pharmacist was looking for information about experimenting shingles rash after the first dose of Shingrix 2 week ago from this report (17th September 2020). The information provided by reporter was not enough, she was offered to call back later with more information but she declined. The reporter consented to follow up. No further information was available.
given injection in afternoon of 9/24/08--at 0100 on 9/25, pt developed vomiting, diarrhea, knee pain and awhile later a fever of 101-              9/26-feels better today
Large red rash appearance around injection site. Began to get bigger. Then part of it disappeared and reappeared further down my arm with pain upon touch or movement.   Woke in the morning with a bad nose bleed (took about 20 minutes to control it)   On birth control, yet I have been having ?spotting? for the past few days and period is not due for another 2 weeks.
Injection: 16:45 in Right Deltoid Reaction: 20:45 ?both armpits are yellow/brown (I?m fair skin toned) and extremely itchy, my throat is very scratchy and sore and I feel very fatigued.
This is a spontaneous report from a contactable nurse via a Pfizer sales representative. A 17-year-old male patient received TRUMENBA, via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced low grade fever, fever, and malaise. The outcome of the events was unknown. Information on the batch/lot number has been requested.
pt recvd vax; devel local rxn which was red, warm; approx 3 1/2 x 1 1/2cm; 24may93 f/u: recovered;
12 hours after receiving vaccine, flu-like lethargy, chills, headache, body ache
She developed cellulitis at the injection site; This spontaneous report has been received from a 48-year-old female nurse, via a company representative, concerning herself. Her current condition included diabetes and her concomitants medications were reported as, 'possibly diabetic medications' (unspecified). Her past medical history and drug allergy or reactions were unknown.   On 31-DEC-2019, the patient was vaccinated with one dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), as prophylaxis (reported as vaccination) (concentration and anatomical location of vaccination were not reported; route of administration, lot number, and expiry date were unknown by the reporter).  That same day,the patient developed cellulitis at the injection site and went to the hospital to seek medical attention where she was administered an epinephrine hydrochloride (EPIPEN). It was unknown if any laboratories diagnostics or studies were performed to the patient. The patient was discharged from the hospital that same day (conflicting information as it was also reported that there was no hospitalization due to the event) with orders to take diphenhydramine hydrochloride (BENADRYL). It was reported that within two days, the swelling began to resolve; and by 30-JAN-2020, the symptoms of cellulitis at the injection site had resolved.   It was reported that cellulitis at the injection site was not considered to be a medically significant, life threatening, disabling, cancerous or overdose event.  The causal relationship between the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and the occurrence of cellulitis at the injection site, was not reported.
toes are very sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (toes are very sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) UNK dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (toes are very sore). At the time of the report, PAIN IN EXTREMITY (toes are very sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications and treatment information was not provided by the reporter.
Student called Health Service stating "received meningitis vaccine 4/28/03. On 5/2/03 developed rash and hives all over body with large wheal at injection site." She also received Yellow Fever on 4/28/03 - no reaction at that site. Rx with Benadryl.
Vaccine administered beyond Expiration date. However, per Moderna- all vaccines met viability requirements.  Completing VAERS per NYS requirements.
No additional adverse event; an expired dose of ROTATEQ was administered to the patient; This spontaneous report was received from a registered nurse (R.N.), concerning a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies, concurrent conditions and concomitant medications were unknown.  On 16-SEP-2022, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, at a dose of 2 milliliter, lot #1741381, expiration date 04-SEP-2022, administered orally for prophylaxis (expired product administered). The patient did not experience any adverse event.  The reporter stated that the vaccine had not been involved in a temperature excursion through the date of administration. No additional information provided.
SkinRash & Rash Narrative:  Patient C/O rash on chest a few minutes after reciving 2nd Pfizer covid vaccine. No SOB. BP 114/85, PO2 100% NAD, alert and conversive.  Mild erythema on chest. No hives.  Released after 30 minutes observation completed in stable condition with instructions to seek medical care if difficulty of brething or hives occur.   Other Relevant History:
Patient developed a round red spot on injection arm below injection site that was warm and somewhat painful about 24 hours after injection.  Treated with Tylenol, benadryl and compresses. as of Tuesday 10-31-23 still apparent on arm
Approximately 12 hours post injection developed severe bilateral leg weakness (inability to walk on my own) headache, body aches, dizziness. I also developed a twitch in my left hand, pinky, index finger and thumb. Developed sharp intermittent pain under my right arm day 4 post injection for several days.
Diagnosed with Covid in the ER; Diagnosed with Covid in the ER; Sick for approximately a week; Effected my ability to do most everything; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID:. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in 2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 12May2022, outcome "unknown" and all described as "Diagnosed with Covid in the ER"; ILLNESS (non-serious) with onset May2022, outcome "recovered" (May2022), described as "Sick for approximately a week"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 2022, outcome "unknown", described as "Effected my ability to do most everything". The events "sick for approximately a week" and "effected my ability to do most everything" required physician office visit. The event "diagnosed with covid in the er" required emergency room visit. Clinical Course: I received my Pfizer vaccine around 01Mar2021. (I don't have my card on me as I type this.) On 12May2022 I was diagnosed with Covid in the ER. I had been sick for approximately a week prior to that. I am still experiencing very challenging symptoms since that time and have had Drs visits.It has effected my ability to do most everything. I don't know who to contact concerning possible follow up treatment. I appreciate any and all direction you can provide me. Thank you so much.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Muscle weakness, pain in arthritic joints, lack of appetite, had to move due to extreme pain
Arrhythmia Heightened PVCs, Couplets  Shortness of breath Fatigue Unable to talk for very long, due to lack of air This has lasted for 7 long, long weeks.  Today I finally feel 100% back to normal
redness at injection site; hot to touch at injection site; pain at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 14th December 2019, the patient received the 1st dose of Shingrix (intramuscular). On 14th December 2019, 2 hrs after receiving Shingrix, the patient experienced injection site erythema, injection site warmth and injection site pain. On an unknown date, the outcome of the injection site erythema, injection site warmth and injection site pain were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema, injection site warmth and injection site pain to be related to Shingrix.  Additional details were received as follows: The patient experienced redness at the injection site, described as about a two inch circle. The patient also noted the site was hot to the touch, and painful.  At time of report, the patient did notice some minor improvement in symptoms. The patient did not consent to follow up.
fatigue; sinus pressure; headache; post nasal drip; dry throat; hot arm feeling; arm soreness; A spontaneous report was received from a consumer concerning a 71-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events arm soreness, fatigue, sinus pressure, headache, post nasal drip, dry throat, hot arm feeling.  The patient's medical history include hypothyroidism, hyperlipidemia and acid reflux disease. Concomitant medications reported were Simvastatin for cholesterol, Levothyroxine for thyroid, Esomeprazole for acid reflux.  On 10 Feb 2021, prior to the onset of the events the patient received their last of two planned doses of mRNA-1273 (lot/batch: 039K20A) intramuscularly for prophylaxis of COVID-19 infection.  On 10 Feb 2021, the patient experienced the event arm soreness . On 11 Feb 2021, the patient experienced the events fatigue, sinus pressure, headache, post nasal drip, dry throat, hot arm feeling.   Treatment details included Took Tylenol XR 2 tabs.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of event- arm soreness was considered resolved on 12 Feb 2021. The outcome of events fatigue, sinus pressure, headache, post nasal drip, dry throat, hot arm feeling  was unknown.
anaphylaxis - treatment ED / ICU epinephrine, famotidine, methylprednisolone
pt recv vax & exp fever of 101, sore throat & white bumps around inside of mouth;
pt recv vax 1AUG95 & 20NOV96 pt devel a rash on head & neck which spread to front & back, light fever;reporter described the rash as not severe;
This spontaneous report was received from a medical assistant, concerning a male patient of unknown age. The patient's medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported. On 09-AUG-2018, the patient was vaccinated with a properly stored but expired dose of ROTATEQ orally, for prophylaxis, lot #M039061 and expiration date 28-MAR-2018 (strength, dose and frequency were not reported). No adverse reactions were reported.
had temp. 98.9 F; arm soreness,feeling lil pain in his arm; redness which is now 3-4 in long at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (redness which is now 3-4 in long at the site of injection), PYREXIA (had temp. 98.9 F) and MYALGIA (arm soreness,feeling lil pain in his arm) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (redness which is now 3-4 in long at the site of injection) and MYALGIA (arm soreness,feeling lil pain in his arm). On an unknown date, the patient experienced PYREXIA (had temp. 98.9 F). At the time of the report, INJECTION SITE ERYTHEMA (redness which is now 3-4 in long at the site of injection), PYREXIA (had temp. 98.9 F) and MYALGIA (arm soreness,feeling lil pain in his arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medication provided
Within 10 minutes of receiving vaccine, got very lightheaded in waves. Got very shaky, felt weak. Felt heart palpitations, increased respirations, shallow breathing Recovered within 30 minutes and returned home. Symptoms have continued since receiving vaccine to include chest pain, feeling jittery/shaky and weak in the limbs
Tingling sensations in my arms and legs on days 3, 4, and 5 after having the shot
the patient felt shortness of breath and chest tightness.  The issue resolved after removing mask for 30 minutes.
Hard spot at that injection site; Fatigue; Fever; Fatigue; Redness is growing in that location; Itchy in the location; Left arm tingling; Irritated in that location; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Left arm tingling), VACCINATION SITE IRRITATION (Irritated in that location), VACCINATION SITE INDURATION (Hard spot at that injection site), VACCINATION SITE PRURITUS (Itchy in the location) and the first episode of FATIGUE (Fatigue) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 02-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jan-2021, the patient experienced VACCINATION SITE INDURATION (Hard spot at that injection site), the first episode of FATIGUE (Fatigue), PYREXIA (Fever) and the second episode of FATIGUE (Fatigue). In January 2021, the patient experienced PARAESTHESIA (Left arm tingling), VACCINATION SITE IRRITATION (Irritated in that location), VACCINATION SITE PRURITUS (Itchy in the location) and VACCINATION SITE ERYTHEMA (Redness is growing in that location). At the time of the report, PARAESTHESIA (Left arm tingling), VACCINATION SITE IRRITATION (Irritated in that location), VACCINATION SITE INDURATION (Hard spot at that injection site), VACCINATION SITE PRURITUS (Itchy in the location), PYREXIA (Fever), VACCINATION SITE ERYTHEMA (Redness is growing in that location) and the last episode of FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        Concomitant product use was not provided by the reporter.  Treatment information included Benadryl and Tylenol, but not confirm whether patient received it.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This is a spontaneous report received from a contactable reporter(s) (consumer or other non-HCP). The reporter is the patient. A 24-year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "recovered", described as "Fatigue for 2.5 days after vaccine". Additional information: Event took place after use of product. Batch and expiry date was unavailable. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I was doing fine until I got COVID-19 last week, I had congestion, fatigue, a little cough but not much, like a cold, I had a COVID-19 home test, and it was negative (Friday night), on Sunday I took another hoe test, and it was positive. I called the doctor on Monday and he prescribed PAXLOVID.
High Fever 104 and vomiting Resolved after 2 days with symptomatic tx
t101 28OCT93-31OCT93 low grade temp 1NOV93, nasal congestion, malaise;
Sunday morning started out with headache then went to a bad headache migraine headache top of head was pounding bad and that lasted half day toke aspirin and git better some, body acky, and fatigue all day, chillis at night when was trying to sleep. Monday some headache, body acky, felling run down, cold and chillis
Gave two patients tetanus toxoid intradermal 0.5ml instead of tuberculin 0.1ml.
Rash and swelling from shoulder to elbow, and sore stiff neck. Treated with Ibuprofen and Benadryl. Lasted two weeks.
Pt. was given vaccines and a few minutes later the pt. complained of not feeling well. The pt. was laying down and I gave the pt. a lollipop and water and the pt was feeling better. The doctor was notified and was with the pt. and her mother in his office and 10-15 mins later the pt lost consciousness.
Patient stated that he felt like a lump appeared near his collar bone/neck. He wasn't sure if it was a swollen lymph node or something else.